Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 232 of 232 entries
View as:

A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.

Phase: N/A Priority: Normal
NCT ID: NCT00389298 Org: User:
Start: 10/31/06 End: 06/30/07 Due: 06/30/08

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

Phase: N/A Priority: Normal
NCT ID: NCT01807923 Org: User:
Start: 05/31/13 End: 04/30/14 Due: 04/30/15

A Study of Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ/TEZ/D-IVA) in Healthy Adult Panelists

Phase: N/A Priority: Normal
NCT ID: NCT06299696 Org: User:
Start: 03/26/24 End: 04/16/24 Due: 04/16/25

Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)

Phase: N/A Priority: Normal
NCT ID: NCT05660538 Org: User:
Start: 12/20/22 End: 10/25/23 Due: 10/25/24

A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF)

Phase: N/A Priority: Normal
NCT ID: NCT03150719 Org: User:
Start: 05/24/17 End: 08/09/18 Due: 08/09/19

A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06392659 Org: User:
Start: 05/02/24 End: 07/02/24 Due: 07/02/25

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

Phase: N/A Priority: Normal
NCT ID: NCT00758043 Org: User:
Start: 10/31/08 End: 07/31/10 Due: 07/31/11